Therapeutic drug monitoring survey of anti-MRSA agents in Japan

Japanese Journal of Chemotherapy

Volumn 58, Issue 2, 2010, Pages 119-124

  Kobayashi, Masahiro ^a   Takesue, Yoshio ^a   Tanigawara, Yusuke ^a   Mikamo, Hiroshige ^a   Kimura, Toshimi ^a   Hirata, Sumio ^a   Shiraishi, Tadashi ^a   Sakaeda, Toshiyuki ^a   Takakura, Shunji ^a  

^a Japanese Society of Chemotherapy   (Japan)

Author keywords

Arbekacin; Questionnaire; Teicoplanin; Therapeutic drug monitoring; Vancomycin

Indexed keywords

HABEKACIN; TEICOPLANIN; VANCOMYCIN;

CLINICAL TRIAL; CONSULTATION; COST BENEFIT ANALYSIS; DRUG BLOOD LEVEL; DRUG COST; DRUG MONITORING; GOVERNMENT; HEALTH INSURANCE; HUMAN; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; PHARMACIST; SHORT SURVEY;

EID: 77950801821     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Rybak M, Lomaestro B, Rotschafer J C, Moellering R Jr, Craig W, Billeter M, et al: Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82-98
2. Gemmell C G. Edwards D I. Fraise A P. Gould F K. Ridgway G L, Warren R E, et al: Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 2006;57:589-608
3. Schentag J J. Jusko W J. Vance J W. Cumbo T J, Abrutyn E, DeLattre M, et al: Gentamicin disposition and tissue accumulation on multiple dosing. J Pharmacokinet Biopharm 1977;5:559-77 (Pubitemid 8253666)
4. http://wwwmnhlw.gojp/shingi/2007/12/dl/sl203-8cpdf
5. th ed. Lippincott Williams & Wilkins, Philadelphia. 2006; p. 285-327